Susquehanna International Group
LSTA icon

Susquehanna International Group’s Lisata Therapeutics LSTA Stock Holding History

Susquehanna International Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,604
Closed -$58.1K – 14059
2026
Q1 		$58.1K Buy
+11,604
New +$47.9K ﹤0.01% 12596
2024
Q4 		– Sell
-11,019
Closed -$33.1K – 12784
2024
Q3 		$33.1K Buy
+11,019
New +$34.7K ﹤0.01% 11512
2024
Q2 		– Sell
-10,719
Closed -$33.4K – 12741
2024
Q1 		$33.4K Sell
10,719
-23,030
-68% -$68.2K ﹤0.01% 11685
2023
Q4 		$92.1K Buy
+33,749
New +$79.2K ﹤0.01% 11393
2022
Q3 		– Sell
-864
Closed -$6.26K – 13740
2022
Q2 		$7K Sell
864
-1,736
-67% -$14.3K ﹤0.01% 12570
2022
Q1 		$28K Buy
2,600
+1,022
+65% +$11.7K ﹤0.01% 12531
2021
Q4 		$20K Sell
1,578
-15,537
-91% -$240K ﹤0.01% 12826
2021
Q3 		$313K Buy
17,115
+15,971
+1,396% +$313K ﹤0.01% 10508
2021
Q2 		$28K Sell
1,144
-5,674
-83% -$134K ﹤0.01% 12392
2021
Q1 		$197K Buy
6,818
+5,372
+372% +$163K ﹤0.01% 11436
2020
Q4 		$31K Sell
1,446
-2,779
-66% -$66K ﹤0.01% 10838
2020
Q3 		$114K Buy
+4,225
New +$134K ﹤0.01% 9839
2020
Q1 		– Sell
-1,363
Closed -$51K – 10612
2019
Q4 		$51K Buy
+1,363
New +$49K ﹤0.01% 9339
2017
Q1 		– Sell
-728
Closed -$31K – 9513
2016
Q4 		$31K Buy
+728
New +$41.8K ﹤0.01% 9372
2016
Q1 		– Sell
-208
Closed -$34K – 9388
2015
Q4 		$34K Sell
208
-224
-52% -$41.1K ﹤0.01% 9164
2015
Q3 		$97K Sell
432
-1,358
-76% -$341K ﹤0.01% 9154
2015
Q2 		$502K Buy
1,790
+1,240
+225% +$461K ﹤0.01% 7630
2015
Q1 		$210K Sell
550
-119
-18% -$64.5K ﹤0.01% 8568
2014
Q4 		$378K Buy
669
+381
+132% +$259K ﹤0.01% 7749
2014
Q3 		$239K Sell
288
-36
-11% -$31.5K ﹤0.01% 8370
2014
Q2 		$317K Buy
324
+66
+26% +$64.2K ﹤0.01% 8278
2014
Q1 		$273K Buy
258
+59
+30% +$64K ﹤0.01% 7734
2013
Q4 		$204K Buy
+199
New +$197K ﹤0.01% 8238

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Susquehanna International Group's LSTA Position: Q2 2026 in Review

Susquehanna International Group sold out of Lisata Therapeutics (LSTA) in Q2 2026, closing a stake of 11,604 shares — an estimated $58.1K sold.

Susquehanna International Group first reported a position in LSTA in Q4 2013 and held it in 23 quarters. The position peaked at $502K in Q2 2015. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Susquehanna International Group reported no remaining Lisata Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 11,604 Lisata Therapeutics shares in Q2 2026, an estimated $58.1K.
  • Susquehanna International Group first reported a position in Lisata Therapeutics in Q4 2013 and held it in 23 quarters.
  • Susquehanna International Group's Lisata Therapeutics position peaked at $502K in Q2 2015.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.